These findings strengthen the pathophysiological relevance of the HGF/RARA/NRP-1 axis in liver fibrosis and highlight hepatocyte NRP-1 as a key therapeutic target for fibrosis intervention. This evidence concerns the gene RARA and Hepatic fibrosis.